Concepedia

Michael P. Ero

MP

4

Publications

205

Citations

4

H-Index

1997

Active since

Affiliations

Klamath Community College(Current)

Michael P. Ero is an author at Klamath Community College specializing in immunology, atherosclerosis, and vascular biology.

Top concepts

Publications per year

1997–2016

4

Publications

4

Consumption of nattokinase is associated with reduced blood pressure and von Willebrand factor, a cardiovascular risk marker: results from a randomized, double-blind, placebo-controlled, multicenter North American clinical trial

Gitte S. Jensen, Miki R. Lenninger, Michael P. Ero et al. · Integrated Blood Pressure Control · 2016 · 68 citations · Full text

von Willebrand factor‐cleaving protease inhibitor in a patient with human immunodeficiency syndrome‐associated thrombotic thrombocytopenic purpura

Mervyn A. Sahud, Susan Claster, Lucy Liu et al. · British Journal of Haematology · 2002 · 52 citations · Full text

Effect of Glycoprotein IIb/IIIa Antagonists on the HIT Serum Induced Activation of Platelets

Walter Jeske, Jeanine M. Walenga, Ewa Szatkowski et al. · Thrombosis Research · 1997 · 49 citations

, , +13

A pilot study on the serum pharmacokinetics of nattokinase in humans following a single, oral, daily dose.

Michael P. Ero, Connie M Ng, Tamara Mihailovski et al. · PubMed · 2013 · 36 citations

Rows per page

1–4 of 4